Mumbai (Maharashtra) [India], January 19: Fineotex Chemical Limited (BSE: 533333 | NSE: FCL), a leading manufacturer of speciality performance chemicals, has approved the allotment of 50,00,000 equity shares pursuant to the conversion of 5,00,000 convertible warrants issued earlier on a preferential basis. The allotment was approved by the Fundraising Committee of the Board at its meeting held on January 17, 2026, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The equity shares, having a face value of ₹1 each, have been issued at an effective price of ₹38.74 per share, including a premium of ₹37.74 per share, following the conversion of warrants originally issued at ₹387.40 per warrant. The company has received an aggregate amount of ₹14.52 crore, representing the balance 75% of the warrant issue price, upon exercise of the warrants. The allotment has been made to Intuitive Alpha Investment Fund PCC – Cell 1, which falls under the Non-Promoter category.
The warrant conversion and subsequent equity allotment have been carried out in compliance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The number of equity shares issued, along with the corresponding face value and premium, has been suitably adjusted to reflect the company's share split and bonus issue approved by shareholders at the Extraordinary General Meeting held on October 25, 2025. The newly allotted equity shares shall rank pari passu with the existing equity shares of the company in all respects.
Consequent to this allotment, the issued and paid-up equity share capital of Fineotex Chemical Limited has increased to ₹116.45 crore, comprising 116.45 crore equity shares of face value ₹1 each. Post allotment, the promoter and promoter group shareholding stands at 61.87%, while the non-promoter shareholding is 38.13%.
The capital infusion further strengthens the company's balance sheet and provides enhanced financial flexibility to support its long-term growth plans, operational expansion, and strategic initiatives. The company continues to focus on strengthening its market position across domestic and international markets through innovation, capacity enhancement, and value-added product offerings.
Disclaimer: This article is for informational purposes only and does not constitute financial advice.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor